Bendamustine 25mg powder for concentrate for solution for infusion vials United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bendamustine 25mg powder for concentrate for solution for infusion vials

dr reddy's laboratories (uk) ltd - bendamustine hydrochloride - powder for solution for infusion - 25mg

Bendamustine 25mg powder for concentrate for solution for infusion vials United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bendamustine 25mg powder for concentrate for solution for infusion vials

zentiva pharma uk ltd - bendamustine hydrochloride - powder for solution for infusion - 25mg

BENDAMUSTINE- bendamustine hcl injection, powder, lyophilized, for solution BENDAMUSTINE- bendamustine hcl injection, powder, l United States - English - NLM (National Library of Medicine)

bendamustine- bendamustine hcl injection, powder, lyophilized, for solution bendamustine- bendamustine hcl injection, powder, l

meitheal pharmaceuticals inc. - bendamustine hydrochloride (unii: 981y8sx18m) (bendamustine - unii:9266d9p3pq) - bendamustine hydrochloride for injection is indicated for the treatment of patients with chronic lymphocytic leukemia. efficacy relative to first line therapies other than chlorambucil has not been established. bendamustine hydrochloride for injection is indicated for the treatment of patients with indolent b-cell non-hodgkin lymphoma that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen. bendamustine hydrochloride is contraindicated in patients with a known hypersensitivity (e.g., anaphylactic and anaphylactoid reactions) to bendamustine [see warnings and precautions (5.4)]. risk summary in animal reproduction studies, intraperitoneal administration of bendamustine to pregnant mice and rats during organogenesis at doses 0.6 to 1.8 times the maximum recommended human dose (mrhd) resulted in embryo-fetal and/or infant mortality, structural abnormalities, and alterations to growth (see data) . there are no available data on bendamustine hydrochloride use i

Bendamustine Accord 25 mg/ml inf. sol. (conc.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bendamustine accord 25 mg/ml inf. sol. (conc.) i.v. vial

accord healthcare b.v. - bendamustine hydrochloride monohydrate 26,14 mg/ml - eq. bendamustine hydrochloride 25 mg/ml - concentrate for solution for infusion - 25 mg/ml - bendamustine hydrochloride monohydrate 26.14 mg/ml - bendamustine

Bendamustine Accord 2,5 mg/ml inj. sol. (pwdr., conc.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bendamustine accord 2,5 mg/ml inj. sol. (pwdr., conc.) i.v. vial

accord healthcare b.v. - bendamustine hydrochloride 25 mg - powder for concentrate for solution for infusion - 2,5 mg/ml - bendamustine hydrochloride 25 mg - bendamustine

Bendamustine Accord 2,5 mg/ml inj. sol. (pwdr., conc.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bendamustine accord 2,5 mg/ml inj. sol. (pwdr., conc.) i.v. vial

accord healthcare b.v. - bendamustine hydrochloride 25 mg - powder for concentrate for solution for infusion - 2,5 mg/ml - bendamustine hydrochloride 100 mg - bendamustine

Bendamustine EG 2.5 mg/ml inj. sol. (pwdr., conc.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bendamustine eg 2.5 mg/ml inj. sol. (pwdr., conc.) i.v. vial

eg sa-nv - bendamustine hydrochloride 25 mg - powder for concentrate for solution for infusion - 2,5 mg/ml - bendamustine hydrochloride 100 mg - bendamustine

Bendamustine EG 2.5 mg/ml inj. sol. (pwdr., conc.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bendamustine eg 2.5 mg/ml inj. sol. (pwdr., conc.) i.v. vial

eg sa-nv - bendamustine hydrochloride 25 mg - powder for concentrate for solution for infusion - 2,5 mg/ml - bendamustine hydrochloride 25 mg - bendamustine

Bendamustine Fresenius Kabi 2,5 mg/ml inj. sol. (pwdr., conc.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bendamustine fresenius kabi 2,5 mg/ml inj. sol. (pwdr., conc.) i.v. vial

fresenius kabi sa-nv - bendamustine hydrochloride 25 mg - powder for concentrate for solution for infusion - 2,5 mg/ml - bendamustine hydrochloride 25 mg - bendamustine

Bendamustine Fresenius Kabi 2,5 mg/ml inj. sol. (pwdr., conc.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bendamustine fresenius kabi 2,5 mg/ml inj. sol. (pwdr., conc.) i.v. vial

fresenius kabi sa-nv - bendamustine hydrochloride 25 mg - powder for concentrate for solution for infusion - 2,5 mg/ml - bendamustine hydrochloride 100 mg - bendamustine